Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India

World Journal of Gastroenterology

Volumn 11, Issue 45, 2005, Pages 7165-7168

  Hussain, Zahid ^a,c   Ali, Syed S ^b   Hussain, Syed A ^c   Raish, Mohammad ^c   Sharma, Deepika R ^b   Kar, Premashis ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b Panacea Biotec Ltd   (India)

^c JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Anti HBs antibody; Enivac HB; Hepatitis B vaccine; Pichia pastoris

Indexed keywords

ENIVAC; HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EDEMA; ERYTHEMA; FATIGUE; FEMALE; FEVER; FUNGAL STRAIN; GEOMETRY; GROUPS BY AGE; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREACTIVITY; INDIA; INFECTION RISK; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL STUDENT; NAUSEA; PARAMEDICAL PERSONNEL; PICHIA PASTORIS; PROSPECTIVE STUDY; SCREENING TEST; SINGLE BLIND PROCEDURE; VOLUNTEER;

EID: 31544443244     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i45.7165     Document Type: Article

References (20)

1. Report of a WHO meeting: prevention of liver cancer, technical report no. 691,World Health Organization, Geneva, 1983: 8-9
2. Ghendon Y. WHO strategy for the global elimination of new cases of hepatitis B. Vaccine 1990; 8 Suppl: S129-133; discussion S134-138
3. Das K, Gupta RK, Kumar V, Kar P. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders. World J Gastroenterol 2003; 9: 1132-1134
4. Thyagarajan SP, Jayararn S, Mohanvalli B. Prevalence of HBV in the general population of India. In: Sarin SK, Singhal AK, editors. Hepatitis B in India: problems and prevention. New Delhi: CBS Publishers, 1996: 5-16
5. Tandon BN. Dimension and issues of HBV control in India Hepatitis B in India: problems and prevention (ed) Sarin SK and Singal AK 1996
6. Chen CJ, You SL, Lin LH, Hsu WL, Yang YW. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol 2002; 32 Suppl: S66-S81
7. Arslanoglu I, Cetin B, Isguven P, Karavus M. Anti-HBs response to standard hepatitis B vaccination in children and adolescents with diabetes mellitus. J PediatrEndocrinol Metab 2002; 15: 389-395
8. Cook IF, Murtagh J. Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants.J Paediatr Child Health 2002; 38: 393-396
9. Abraham B, Baine Y, De-Clercq N, Tordeur E, Gerard PP, Manouvriez PL, Parenti DL. Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine. Antiviral Res 2002; 53: 63-73
10. Cassidy WM. Adolescent hepatitis B vaccination. A review. Minerva Pediatr 2001; 53: 559-566
11. Elkayam O, Yaron M, Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 2002; 61: 623-625
12. Cregg JM, Vedvick TS, Raschke WC. Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology (N Y) 1993; 11: 905-910
13. Belloni C, Pistorio A, Tinelli C, Komakec J, Chirico G, Rovelli D, Gulminetti R, Comolli G, Orsolini P, Rondini G. Early immunisation with hepatitis B vaccine: a five-year study. Vaccine 2000; 18: 1307-1311
14. Valenzuela P, Gray P, Quiroga M, Zaldivar J, Goodman HM, Rutter WJ. Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature 1979; 280: 815-819
15. Elavia AJ, Marfatia SP, Banker DD. Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine. Vaccine 1994; 12: 87-90
16. Looney RJ, Hasan MS, Coffin D, Campbell D, Falsey AR, Kolassa J, Agosti JM, Abraham GN, Evans TG. Hepatitis B immunization of healthy elderly adults: relationship between naive CD4+ T cells and primary immune response and evaluation of GM-CSF as an adjuvant. J Clin Immunol 2001; 21: 30-36
17. Bennett RG, Powers DC, Remsburg RE, Scheve A, Clements ML. Hepatitis B virus vaccination for older adults. J Am Geriatr Soc 1996; 44: 699-703
18. Jilg W, Lorbeer B, Schmidt M, Wilske B, Zoulek G, Deinhardt F. Clinical evaluation of a recombinant hepatitis B vaccine. Lancet 1984; 2: 1174-1175
19. Dentico P, Buongiorno R, Volpe A, Zavoianni A, Pastore G, Schiraldi O. Long-term immunogenicity safety and efficacy of a recombinant hepatitis B vaccine in healthy adults. Eur J Epidemiol 1992; 8: 650-655
20. Marsano LS, Greenberg RN, Kirkpatrick RB, Zetterman RK, Christiansen A, Smith DJ, DeMedina MD, Schiff ER. Comparison of a rapid hepatitis B immunization schedule to the standard schedule for adults. Am J Gastroenterol 1996; 91: 111-115